Dr. Gene L Hwang, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 S Whittaker St, New Buffalo, MI 49117 Phone: 269-469-0202 |
News Archive
COVID-19 is a spreading viral illness, mostly mild but fatal in the sick and elderly. At present, it has affected almost 200,000 people, with nearly 8,000 deaths worldwide. Governments around the world are formulating and executing new guidelines to control the spread of the virus. In the latest guidelines, pregnant women join the list of individuals who must stay away from all social contact for 12 weeks to limit the spread of the virus and deaths due to the illness.
The findings, released today by the AAA Foundation for Traffic Safety, indicate that 95 percent of those age 55 and older have one or more medical conditions, 78 percent take one or more medications, and only 28 percent have an awareness of the risks those medications might have on driving ability.
Transave Inc., today reported additional positive clinical trial results on its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation), an antibiotic that aims to treat chronic lung infections.
Rigel Pharmaceuticals, Inc. has announced the presentation of clinical data for R112, the company's lead candidate for the treatment of allergic rhinitis, during a poster session at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) in San Francisco, CA. The phase I/II single dose trial demonstrated that R112 was well tolerated and showed favorable biological effects.
Maine was granted leeway — the first such waiver given by the federal government — with the health law provision known as the medical-loss ratio because of concerns it would destabilize the state's insurance market.
› Verified 7 days ago